DURHAM, NC / ACCESS Newswire / July 16, 2025 / On Glioblastoma Awareness Day, the Glioblastoma Foundation proudly announces the official launch of Gliolab, a CLIA-certified genomic testing laboratory ...

A study published by Caris showed that certain tumor types had very low or no HER2 overexpression, which has implications for biomarker testing strategies.

Current CRISPR guide RNAs are designed based on European reference genomes, leading to false-negative results in cells from ...